Table 4 Top 10 diminished proteins identified in CR compared to CN ascites tumor cells.

From: Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells

Protein Accession

Gene symbol

Protein Description

CN

CR

RSC

Gene ontology (GO)

B7Z416

DHRS9

Dehydrogenase/reductase SDR family member 9

48

46

−13.0

oxidation-reduction process; oxidoreductase activity

Q16647

PTGIS

Prostacyclin synthase

43

40

−8.7

apoptotic signaling pathway; cellular response to hypoxia; cellular response to interleukin-1; cellular response to interleukin-6; cyclooxygenase pathway; endoplasmic reticulum membrane; extracellular space; heme binding; integral component of membrane; iron ion binding; monooxygenase activity; negative regulation of NF-kappaB transcription factor activity; negative regulation of inflammatory response; negative regulation of nitric oxide biosynthetic process; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; positive regulation of angiogenesis; positive regulation of execution phase of apoptosis; positive regulation of peroxisome proliferator activated receptor signaling pathway; prostaglandin-I synthase activity; xenobiotic metabolic process

B4DKB2

ECE1

Endothelin-converting enzyme 1

42

38

−6.7

metalloendopeptidase activity; proteolysis

K7EKI8

PPL

Periplakin

211

187

−6.4

cytoskeleton

P26583

HMGB2

High mobility group protein B2

14

13

−5.7

DNA binding, bending; DNA topological change; RAGE receptor binding; apoptotic DNA fragmentation; base-excision repair, DNA ligation; cell chemotaxis; cellular response to lipopolysaccharide; chemoattractant activity; damaged DNA binding; double-stranded DNA binding; extracellular space; male gonad development; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; negative regulation of transcription, DNA-templated; nucleosome assembly; phosphatidylinositol-mediated signaling; positive regulation of DNA binding; positive regulation of endothelial cell proliferation; positive regulation of erythrocyte differentiation; positive regulation of megakaryocyte differentiation; positive regulation of nuclease activity; positive regulation of transcription from RNA polymerase II promoter; protein complex; response to steroid hormone; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription regulatory region DNA binding

P09913

IFIT2

Interferon-induced protein with tetratricopeptide repeats 2

14

13

−5.7

RNA binding; apoptotic mitochondrial changes; cellular response to interferon-alpha; cytosol; defense response to virus; endoplasmic reticulum; negative regulation of protein binding; positive regulation of apoptotic process; response to virus; type I interferon signaling pathway

Q13753

LAMC2

Laminin subunit gamma-2

34

30

−5.3

cell adhesion; cell cortex; epidermis development; extracellular matrix organization; extracellular region; extracellular space; hemidesmosome assembly; heparin binding; laminin-2 complex; laminin-5 complex; membrane; perinuclear region of cytoplasm

A8K8G0

HDGF

Hepatoma-derived growth factor

33

29

−5.1

NA

P43155

CRAT

Carnitine O-acetyltransferase

12

11

−4.9

carnitine O-acetyltransferase activity; carnitine metabolic process, CoA-linked; endoplasmic reticulum; fatty acid beta-oxidation using acyl-CoA oxidase; mitochondrial inner membrane; mitochondrion; peroxisomal matrix; transport

P08582

MFI2

Melanotransferrin (Melanoma-associated antigen p97) (CD228)

12

11

−4.9

anchored component of membrane; cellular iron ion homeostasis; extracellular region; ferric iron binding; integral component of plasma membrane; iron ion binding; iron ion transport

  1. Rsc: Spectral count ratio (CR /CN), NA: Not available.